Latest AH Capital Management, L.L.C. Stock Portfolio
$1.29Billion | No. of Holdings #16
AH Capital Management, L.L.C. Performance
2026 Q1-19.89%
YTD-19.89%
2025-6.56%
About AH Capital Management, L.L.C. and 13F Hedge Fund Stock Holdings
On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, a16z Capital Management, L.L.C. reported an equity portfolio of $1.3 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of a16z Capital Management, L.L.C. are , , META. The fund has invested 29% of it's portfolio in NAVAN INC and 26.2% of portfolio in FIGMA INC. <br><br> The fund managers got completely rid off HERITAGE COMM CORP (HTBK) stocks. They significantly reduced their stock positions in OMADA HEALTH INC. a16z Capital Management, L.L.C. opened new stock positions in DAMORA THERAPEUTICS INC (GLTO) and AKTIS ONCOLOGY INC. The fund showed a lot of confidence in some stocks as they added substantially to NAVAN INC.
AH Capital Management, L.L.C. Equity Portfolio Value
Last Reported on: 15 May, 2026
$1.29Billion
as of May 15, 2026AH Capital Management, L.L.C. Annual Return Estimates Vs S&P 500
Our best estimate is that a16z Capital Management, L.L.C. made a return of -19.89% in the last quarter. In trailing 12 months, it's portfolio return was -18.38%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| damora therapeutics inc | 32,016,500 |
| aktis oncology inc | 7,424,350 |
| bitgo holdings inc | 5,484,110 |
| ip strategy holdings inc | 21,843 |
New stocks bought by AH Capital Management, L.L.C.
Additions
| Ticker | % Inc. |
|---|---|
| navan inc | 3.76 |
Additions to existing portfolio by AH Capital Management, L.L.C.
Reductions
| Ticker | % Reduced |
|---|---|
| omada health inc | -33.33 |
| figma inc | -1.44 |
AH Capital Management, L.L.C. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| heritage comm corp | -129,074 |
AH Capital Management, L.L.C. got rid off the above stocks
Sector Distribution
a16z Capital Management, L.L.C. has about 67.5% of it's holdings in Others sector.
- Others
- Healthcare
- Communication Services
- Technology
| Sector | % |
|---|---|
| Others | 67.5 |
| Healthcare | 18.4 |
| Communication Services | 9.4 |
| Technology | 4.7 |
Market Cap. Distribution
a16z Capital Management, L.L.C. has about 21.1% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- LARGE-CAP
- MEGA-CAP
- MICRO-CAP
- MID-CAP
- NANO-CAP
| Category | % |
|---|---|
| UNALLOCATED | 67.5 |
| LARGE-CAP | 11.7 |
| MEGA-CAP | 9.4 |
| MICRO-CAP | 5.3 |
| MID-CAP | 3.6 |
| NANO-CAP | 2.5 |
Stocks belong to which Index?
About 25.2% of the stocks held by a16z Capital Management, L.L.C. either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
- S&P 500
| Index | % |
|---|---|
| Others | 74.7 |
| RUSSELL 2000 | 15.8 |
| S&P 500 | 9.4 |
AH Capital Management, L.L.C. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of AH Capital Management, L.L.C.
a16z Capital Management, L.L.C. has 16 stocks in it's portfolio. About 96% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. ERAS was the most profitable stock for a16z Capital Management, L.L.C. last quarter.
$1.29BTotal Value
17.00Positions
15 May, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Ginkgo Bioworks Holdings Inc AH Capital Management, L.L.C.'s holding in Ginkgo Bioworks Holdings Inc over time | 0.05% | 108,568 | $665.5K 0.05% | 0%unchanged 0 percentunchanged | |
 Erasca Inc Erasca IncERAS AH Capital Management, L.L.C.'s holding in Erasca Inc over time | 3.59% | 2,862,500 | $46.32M 3.59% | 0%unchanged 0 percentunchanged | |
 Damora Therapeutics Inc AH Capital Management, L.L.C.'s holding in Damora Therapeutics Inc over time | 2.48% | 1,236,160 | $32.02M 2.48% | Newnew position | |
 Heritage Comm Corp AH Capital Management, L.L.C.'s holding in Heritage Comm Corp over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Meta Platforms Inc AH Capital Management, L.L.C.'s holding in Meta Platforms Inc over time | 9.42% | 212,531 | $121.59M 9.42% | 0%unchanged 0 percentunchanged | |
 Nautilus Biotechnology Inc AH Capital Management, L.L.C.'s holding in Nautilus Biotechnology Inc over time | 5.31% | 17,653,900 | $68.50M 5.31% | 0%unchanged 0 percentunchanged | |
 Revolution Medicines Inc AH Capital Management, L.L.C.'s holding in Revolution Medicines Inc over time | 6.94% | 921,099 | $89.58M 6.94% | 0%unchanged 0 percentunchanged | |
| 4.74% | 1,016,700 | $61.18M 4.74% | 0%unchanged 0 percentunchanged | ||
Cl A Navan IncNavan Inc | 28.95% | 28,218,700 | $373.62M 28.95% | 3.76%increased 3.76 percentadded | |
Class A Com Stk Figma IncFigma Inc | 26.23% | 16,011,400 | $338.48M 26.23% | 1.44%decreased 1.44 percentreduced | |
Com Bioage Labs IncBioage Labs Inc | 4.38% | 3,233,170 | $56.55M 4.38% | 0%unchanged 0 percentunchanged | |
Com Maze Therapeutics IncMaze Therapeutics Inc | 3.94% | 1,702,220 | $50.81M 3.94% | 0%unchanged 0 percentunchanged | |
Com Omada Health IncOmada Health Inc | 2.25% | 2,307,280 | $29.00M 2.25% | 33.33%decreased 33.33 percentreduced | |
Com Camp4 Therapeutics CorpCamp4 Therapeutics Corp | 0.73% | 2,125,340 | $9.37M 0.73% | 0%unchanged 0 percentunchanged | |
Com Aktis Oncology IncAktis Oncology Inc | 0.58% | 415,000 | $7.42M 0.58% | Newnew position | |
Com Shs Cl A Bitgo Holdings IncBitgo Holdings Inc | 0.42% | 666,356 | $5.48M 0.42% | Newnew position | |
Com Ip Strategy Holdings IncIp Strategy Holdings Inc | 0% | 82,740 | $21.8K 0% | Newnew position | |
